Evidence map›Paper›PMID 33440184›Full record

ArticleChest2021

Novel Machine Learning Can Predict Acute Asthma Exacerbation.

Joe G Zein, Chao-Ping Wu, Amy H Attaway, Peng Zhang, Aziz Nazha

Open access · greenAbstract read
In one paragraph

Article in Chest, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 4 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 4 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Development and validation of a long-term survival prediction model for older adults with asthma.Archives of public health = Archives belges de sante publique · 2026
    Article
  11. Review
  12. Article
  13. Multimodal EHR-Based Prediction of Pediatric Asthma Exacerbations.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. AI model for predicting asthma prognosis in children.The journal of allergy and clinical immunology. Global · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Joe G ZeinRespiratory Institute, Cleveland Clinic, Cleveland, OH; Lerner Research Institute, Cleveland Clinic, Cleveland, OH. Electronic address: zeinj@ccf.org.
Chao-Ping WuRespiratory Institute, Cleveland Clinic, Cleveland, OH.
Amy H AttawayRespiratory Institute, Cleveland Clinic, Cleveland, OH; Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Peng ZhangRespiratory Institute, Cleveland Clinic, Cleveland, OH.
Aziz NazhaLerner Research Institute, Cleveland Clinic, Cleveland, OH; Center for Clinical Artificial Intelligence, Cleveland Clinic, Cleveland, OH; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Cleveland Clinic · USCleveland Clinic Lerner College of Medicine · US

Funding

Gender-based precision care for asthmaK08HL133381 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI ZEIN, JOE · 2017 to 2021
$836k
NHLBI NIH HHS K08 HL133381
6 · The paper itself

Abstract

backgroundAsthma exacerbations result in significant health and economic burden, but are difficult to predict. RESEARCH QUESTION: Can machine learning (ML) models with large-scale outpatient data predict asthma exacerbations? STUDY DESIGN AND

methodsWe analyzed data extracted from electronic health records (EHRs) of asthma patients treated at the Cleveland Clinic from 2010 through 2018. Demographic information, comorbidities, laboratory values, and asthma medications were included as covariates. Three different models were built with logistic regression, random forests, and a gradient boosting decision tree to predict: (1) nonsevere asthma exacerbation requiring oral glucocorticoid burst, (2) ED visits, and (3) hospitalizations.

resultsOf 60,302 patients, 19,772 (32.8%) had at least one nonsevere exacerbation requiring oral glucocorticoid burst, 1,748 (2.9%) requiring and ED visit and 902 (1.5%) requiring hospitalization. Nonsevere exacerbation, ED visit, and hospitalization were predicted best by light gradient boosting machine, an algorithm used in ML to fit predictive analytic models, and had an area under the receiver operating characteristic curve of 0.71 (95% CI, 0.70-0.72), 0.88 (95% CI, 0.86-0.89), and 0.85 (95% CI, 0.82-0.88), respectively. Risk factors for all three outcomes included age, long-acting β agonist, high-dose inhaled glucocorticoid, or chronic oral glucocorticoid therapy. In subgroup analysis of 9,448 patients with spirometry data, low FEV

interpretationModels built with an ML algorithm from real-world outpatient EHR data accurately predicted asthma exacerbation and can be incorporated into clinical decision tools to enhance outpatient care and to prevent adverse outcomes.

Indexed as

Machine LearningSymptom Flare UpAdolescentAdultAgedAged, 80 and overAsthmaElectronic Health RecordsFemaleHumansMaleMiddle AgedOhioPredictive Value of Testsacute asthma exacerbationasthmamachine learning

Identifiers

PMID33440184
PMCPMC8129731
OpenAlexW3118385223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.